4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001181431-10-010942
Options or other derivatives
- SVP & GENERAL COUNSEL acquired 6,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ozeroff Christopher David · SVP & GENERAL COUNSEL
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-02-18 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +6,400 | $2.97 | 2020-02-18 | 6,400 | 6,400 | D |
Loading xslF345X03/rrd266113.xml…